Literature DB >> 15172741

Challenges and directions for the pathogen hypothesis of Alzheimer's disease.

Stephen R Robinson1, Curtis Dobson, Joseph Lyons.   

Abstract

This paper critically reviews the possibility that infiltration of the brain by pathogens (e.g. Herpes simplex virus type 1 (HSV1) or Chlamydophila pneumoniae (Cp)) acts as a trigger or co-factor for Alzheimer's disease (AD). The evidence currently available is limited and in some cases inconsistent, but it does justify the need for more vigorous investigation of this hypothesis. An issue of particular concern is the paucity of experimental evidence showing that pathogens can elicit the neuropathological changes and cognitive deficits that characterise AD. Other weaknesses include a failure to obtain independent confirmation of Cp in AD brains, and a lack of evidence for HSV1 proteins or intact virions in AD brain tissue. Future avenues of investigation that might prove fruitful include epidemiological investigations of the incidence of AD in individuals who are either immunosuppressed or have received chronic antiviral or antibiotic therapy. There is also a need to consider systemic infections as potential contributors to the pathogenesis of AD.

Entities:  

Mesh:

Year:  2004        PMID: 15172741     DOI: 10.1016/j.neurobiolaging.2003.12.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

Review 2.  Antimicrobial properties of amyloid peptides.

Authors:  Bruce L Kagan; Hyunbum Jang; Ricardo Capone; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  Mol Pharm       Date:  2011-11-29       Impact factor: 4.939

Review 3.  Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  Clive Holmes; Darren Cotterell
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

4.  Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.

Authors:  S Duleu; A Mangas; F Sevin; B Veyret; A Bessede; M Geffard
Journal:  Int J Alzheimers Dis       Date:  2010-03-15

5.  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.

Authors:  Jannis Kountouras; Marina Boziki; Emmanuel Gavalas; Christos Zavos; Nikolaos Grigoriadis; Georgia Deretzi; Dimitrios Tzilves; Panagiotis Katsinelos; Magda Tsolaki; Dimitrios Chatzopoulos; Ioannis Venizelos
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

6.  Octodon degus: a strong attractor for Alzheimer research.

Authors:  Rafael Castro-Fuentes; Rosario Socas-Pérez
Journal:  Basic Clin Neurosci       Date:  2013

Review 7.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

Review 8.  Is Alzheimer's disease an infectious neurological disease? A review of the literature.

Authors:  Olivier Uwishema; Ashraf Mahmoud; Jeffrey Sun; Inês F Silva Correia; Niovi Bejjani; Maria Alwan; Aderinto Nicholas; Adekunbi Oluyemisi; Burhan Dost
Journal:  Brain Behav       Date:  2022-07-25       Impact factor: 3.405

9.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

Review 10.  Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis.

Authors:  Christopher M Henstridge; Bradley T Hyman; Tara L Spires-Jones
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.